23andMe Is Launching a $1,200-a-Year Service To Find Health Risks In Your DNA
Gene-testing company is transitioning into a health-care company.
The service allows people to sequence their entire exome, the tiny portion of DNA that researchers estimate is responsible for the vast majority of disease-causing genes.
Photographer: Tiffany Hagler-Geard/Bloomberg23andMe Holding Co., the genetic-testing company best known for helping people discover their ancestral roots and inherited food aversions, is rolling out a new product to help customers better understand and manage health risks hidden in their DNA.
The service — available in November for $1,188 a year — allows people to sequence their entire exome, the tiny portion of DNA that researchers estimate is responsible for the vast majority of disease-causing genetic variants. Customers will also be connected to health-care practitioners who can help them manage genetic vulnerabilities, and receive twice-yearly blood tests to check their progress.